Mylan Launches Generic Sporanox Capsules

Mylan Inc. announced that it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Itraconazole Capsules, 100mg.

This product is the generic version of Janssen Pharmaceutical Inc.‘s Sporanox and is indicated for the treatment of fungal infections that begin in the lungs, blatsomycosis, histoplasmosis, and aspergillosis in patients who are intolerant of or who are refractory to amphotericin B therapy. Itraconazole capsules are also indicated for the treatment of fungal infections of the toenails and fingernails in non-immunocompromised patients.

For more information call (800) RX-MYLAN or visit www.mylan.com.